Anti-tumor drug, medicament, composition, and use thereof
Details for Australian Patent Application No. 2008237952 (hide)
International Classifications
Event Publications
5 November 2009 PCT application entered the National Phase
PCT publication WO2008/125635 Priority application(s): WO2008/125635
1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
8 December 2011 Corrigenda
Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2008 Delete all reference to Application No. 2008237952.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008237959-Process for operating a partial oxidation process of a solid carbonaceous feed
2008237944-Pyridazine-, pyridineand pyranederivatives as GPBAR1 agonisis
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser